Stockreport

An Intrinsic Calculation For Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) Suggests It's 50% Undervalued [Yahoo! Finance]

Alnylam Pharmaceuticals, Inc.  (ALNY) 
Last alnylam pharmaceuticals, inc. earnings: 2/6 08:00 am Check Earnings Report
US:NASDAQ Investor Relations: investors.alnylam.com/investor-overview
PDF Alnylam Pharmaceuticals' US$249 share price signals that it might be 50% undervalued Our fair value estimate is 97% higher than Alnylam Pharmaceuticals' analyst price [Read more]